299 related articles for article (PubMed ID: 9604875)
1. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
Ng TF; Lee FK; Song ZT; Calcutt NA; Lee AY; Chung SS; Chung SK
Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
3. Sorbitol, inositol and nerve conduction in diabetes.
Gillon KR; Hawthorne JN
Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
[TBL] [Abstract][Full Text] [Related]
4. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
5. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
Whiteley SJ; Tomlinson DR
Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
7. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
[TBL] [Abstract][Full Text] [Related]
8. Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats.
Shinohara R; Mano T; Nagasaka A; Sawai Y; Uchimura K; Hayashi R; Hayakawa N; Nagata M; Makino M; Kakizawa H; Itoh Y; Nakai A; Itoh M
Biochim Biophys Acta; 1998 Nov; 1425(3):577-86. PubMed ID: 9838221
[TBL] [Abstract][Full Text] [Related]
9. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.
Matsumoto T; Ono Y; Kurono M; Kuromiya A; Nakamura K; Bril V
J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096
[TBL] [Abstract][Full Text] [Related]
10. Aberrant mRNA splicing causes sorbitol dehydrogenase deficiency in C57BL/LiA mice.
Lee FK; Chung SK; Chung SS
Genomics; 1997 Nov; 46(1):86-92. PubMed ID: 9403062
[TBL] [Abstract][Full Text] [Related]
11. Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats.
Hoshi A; Takahashi M; Fujii J; Myint T; Kaneto H; Suzuki K; Yamasaki Y; Kamada T; Taniguchi N
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):119-23. PubMed ID: 8761460
[TBL] [Abstract][Full Text] [Related]
12. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
Tomlinson DR; Robinson JP; Compton AM; Keen P
Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
[TBL] [Abstract][Full Text] [Related]
13. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
[TBL] [Abstract][Full Text] [Related]
14. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
Hirata Y; Fujimori S; Okada K
Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
[TBL] [Abstract][Full Text] [Related]
15. Comparison of glucose, sorbitol and fructose accumulation in lens and liver of diabetic and insulin-treated rats and mice.
Gaynes BI; Watkins JB
Comp Biochem Physiol B; 1989; 92(4):685-90. PubMed ID: 2498032
[TBL] [Abstract][Full Text] [Related]
16. Localization of aldose reductase and sorbitol dehydrogenase in the nervous system of normal and diabetic rats.
Orosz SE; Townsend SF; Tornheim PA; Brownscheidle CM
Acta Diabetol Lat; 1981; 18(4):373-81. PubMed ID: 6800175
[TBL] [Abstract][Full Text] [Related]
17. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
Collins JG; Corder CN
Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
[TBL] [Abstract][Full Text] [Related]
19. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation.
Chan AW; Ho YS; Chung SK; Chung SS
Exp Eye Res; 2008 Nov; 87(5):454-61. PubMed ID: 18760274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
